Much like BRN , Weebit Nano (ASX:WBT) finds its self 6 months behind BrainChip.
Following the recent capital raising, the uncertainty around the company’s funding has been substantially reduced. In turn this has substantially reduced the investment risk for WBT.
Additionally, helped by the enlarged financial runway, the company is now in a position to accelerate its various development programs, which increases the chances of WBT being able to address multiple markets in due time. In other words, the chances that the company can actually address the multiple commercial opportunities out there have greatly increase
WBT recently reaffirmed that it expects to be able to sign a commercial deal for the embedded memory module by mid-2021. This would put it around 6 months behind BrainChip when it comes to first commercialisation.
WBT recently raised $15m (before costs) through an institutional placement and a Share Purchase Plan (SPP). Combined with the raise in mid-2020 and assuming a quarterly cash burn of $1.2m, WBT now has a comfortable cash position of around $19m per 1 January 2021.
Following the raise and the fact that there are nearly 44m deep in-the-money options outstanding that can bring in an estimated $20m in funding, the company is de-risked from a funding point of view.
Initiation report by Frost & Sullivan, a US-based Independant Equity Research company.
Their current valuation is USD 3.00, so around $3.90.
Weebit's report was as expected. They have never wavered from their program other than accelerating development in associated domains with the additional funds raised over the past few months. Upcoming announcements over the next six months with prove the potential of this company.
26 February 2021
Key highlights for H1FY21
Targeting first commercial agreement in the embedded market mid-2021.
Targeting the discrete market 2024.
See the slide below from the recent Webinar presentation released on 29/1/21.
The size of the potential markets is what makes WBT such an exciting investment. Still high risk, but the rewards could be a slice of these:
Company Presentation on Outlook through 2021.
Should be able to get it here
Best to read the company announcements and interviews (stocks down under, pitt st research).
Essentially they have new silicon based non-volatile ram storage which can be stacked, and which offers higher speeds. Because it uses familiar fab technology it should be easier to get to production from where it is at now.
Will be volatile, but expect good news thru 2021.
(Figure .9 achievable in short term. DYOR. old post just a month ago)
Currently $2, expect continuing volatility.
Refer to the company website for the latest presentation.
The marektplace for non-volatile memory is held back by limitations in data volume that can be written at reasonable speed.
WBTs technology addresses both speed and capacity.
As you will see from the October 2020 post, they are ready to produce samples and are approacing Tier 2 companies in order to get early revenue.
The NVM market is $60b, but the initial focus area is a $2b segment. DYOR.
I hold both WBT and WBTOA in the real world.
A good result with the stabalisation process completed exceeding expectations bringing the level of functional cells to over 99% now closer to commercialisation and in talks with production partners.
Further confirmation with yesterdays announcement that the Leti/WBT collaboration is producing results. WBT has completed this milestone, once again ahead of schedule, consistent with the overdelivering history in milestone announcements.
"WBT successfully completed the first stage of the “stabilisation” process, a key milestone on the path to productisation.
The aim of this phase was to verify that Weebit’s production process is repeatable and consistent, to reduce chances for defects and therefore improve the wafer yield."
RERAM tech is on its way and exciting times with it!
Well, here we go again. Another capital raising. I have been following this stock since its listing in 2015 and have been an investor since 2017. I definitely could/should have waited until they were further ahead in their development and didn't have to suffer through numerous capital raisings, most of them dilutive, while one was consolidating. I am a patient investor who bought because I love the story (history shows this is not the most viable tactic) and am a firm believer in what their product will achieve and how I will benefit in the future. It's what my investing thesis entails. I remain a faithful and will be taking up another allotment, for they have a new product with a huge addressable market in ever expanding fields using semiconductors. The board of directors is as strong as any listed on the ASX, with a vast weath of knowledge and experience. They are also current shareholders. The road from development to revenue is unpredictable, but......their day will come. Until then, I will to continue following my mantra of patience, patience, patience. DYOR
This is an addendum to the above. The capital raise was extremely successful (though once again dilutive), raising 5 fold+ the amount of funds originally planned. They are now locked and loaded, with 10 million in the bank. It's now time for the financial side of the business to match the technical one. With a well connected BOD and a quiver of potential applications running far into the future, the next 9-12 should (will) see the company become the butterfly no one yet sees. Patience, Patience, Patience.